MedPath

Asthma in the Elderly: The Role of Vitamin D

Phase 3
Completed
Conditions
Asthma in the Elderly
Interventions
Dietary Supplement: Vitamin D 2,000 I.U.
Registration Number
NCT01730976
Lead Sponsor
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Brief Summary

We will study whether taking vitamin D improves asthma control and spirometric values in elderly asthmatics.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Asthma, age of 65 years old or older
Exclusion Criteria
  • Current smokers, subjects who smoked more than 10 pack/year, subjects taking digoxin, subjects with liver disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Vitamin D 2,000 I.U. dailyVitamin D 2,000 I.U.Study subjects will take 2,000 I.U. vitamin D daily for three months
Primary Outcome Measures
NameTimeMethod
Improvement in Asthma Control Test (ACT) scoreThree months
Secondary Outcome Measures
NameTimeMethod
Improvement in pulmonary function tests values (FEV1%, etc.)Three months

Trial Locations

Locations (1)

Rohr and Columbo Asthma, Allergy and Immunology Specialists

🇺🇸

Bryn Mawr, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath